Reduced cell turnover in lymphocytic monkeys infected by human T-lymphotropic virus type 1

被引:9
作者
Debacq, C
Héraud, JM
Asquith, B
Bangham, C
Merien, F
Moules, V
Mortreux, F
Wattel, E
Burny, AN
Kettmann, R
Kazanji, M
Willems, L
机构
[1] FUSAG, Ctr Basic Biol, B-5030 Gembloux, Belgium
[2] Inst Pasteur, Lab Retrovirol, Cayenne, French Guiana
[3] Imperial Coll Sch Med, Dept Immunol, London, England
[4] Ctr Leon Berard, CNRS UMR 5537, Unite Oncogenese Virale, F-69373 Lyon, France
基金
英国惠康基金;
关键词
HTLV-1; leukemia; BrdU; turnover;
D O I
10.1038/sj.onc.1208896
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Understanding cell dynamics in animal models have implications for therapeutic strategies elaborated against leukemia in human. Quanti. cation of the cell turnover in closely related primate systems is particularly important for rare and aggressive forms of human cancers, such as adult T-cell leukemia. For this purpose, we have measured the death and proliferation rates of the CD4(+) T lymphocyte population in squirrel monkeys (Saimiri sciureus) infected by human T-lymphotropic virus type 1 (HTLV-1). The kinetics of in vivo bromodeoxyuridine labeling revealed no modulation of the cell turnover in HTLV-1-infected monkeys with normal CD4 cell counts. In contrast, a substantial decrease in the proliferation rate of the CD4(+) T population was observed in lymphocytic monkeys (e.g. characterized by excessive proportions of CD4(+) T lymphocytes and by the presence of abnormal flower-like cells). Unexpectedly, onset of HTLV-associated leukemia thus occurs in the absence of increased CD4(+) T-cell proliferation. This dynamics significantly differs from the generalized activation of the T-cell turnover induced by other primate lymphotropic viruses like HIV and SIV.
引用
收藏
页码:7514 / 7523
页数:10
相关论文
共 56 条
[31]   HTLV-I AND UVEITIS [J].
MOCHIZUKI, M ;
YAMAGUCHI, K ;
TAKATSUKI, K ;
WATANABE, T ;
MORI, S ;
TAJIMA, K .
LANCET, 1992, 339 (8801) :1110-1110
[32]   Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy [J].
Mohri, H ;
Perelson, AS ;
Tung, K ;
Ribeiro, RM ;
Ramratnam, B ;
Markowitz, M ;
Kost, R ;
Hurley, A ;
Weinberger, L ;
Cesar, D ;
Hellerstein, MK ;
Ho, DD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1277-1287
[33]   Rapid turnover of T lymphocytes in SIV-infected rhesus macaques [J].
Mohri, H ;
Bonhoeffer, S ;
Monard, S ;
Perelson, AS ;
Ho, DD .
SCIENCE, 1998, 279 (5354) :1223-1227
[34]   Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo [J].
Mortreux, F ;
Leclercq, I ;
Gabet, AS ;
Leroy, A ;
Westhof, E ;
Gessain, A ;
Wain-Hobson, S ;
Wattel, E .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (05) :367-377
[35]   Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus) [J].
Mortreux, F ;
Kazanji, M ;
Gabet, AS ;
de Thoisy, B ;
Wattel, E .
JOURNAL OF VIROLOGY, 2001, 75 (02) :1083-1089
[36]   Immunological hyperresponsiveness in HTLV-1 LTR-env-pX transgenic rats: A prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases [J].
Nakamaru, Y ;
Ishizu, A ;
Ikeda, H ;
Sugaya, T ;
Fugo, K ;
Higuchi, M ;
Yamazaki, H ;
Yoshiki, T .
PATHOBIOLOGY, 2001, 69 (01) :11-18
[37]   Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model [J].
Ohashi, T ;
Hanabuchi, S ;
Suzuki, R ;
Kato, H ;
Masuda, T ;
Kannagi, M .
JOURNAL OF VIROLOGY, 2002, 76 (14) :7010-7019
[38]   Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine [J].
Ohashi, T ;
Hanabuchi, S ;
Kato, H ;
Tateno, H ;
Takemura, F ;
Tsukahara, T ;
Koya, Y ;
Hasegawa, A ;
Masuda, T ;
Kannagi, M .
JOURNAL OF VIROLOGY, 2000, 74 (20) :9610-9616
[39]  
OSAME M, 1986, LANCET, V1, P1031
[40]   HYPERINFECTION WITH STRONGYLOIDES AFTER TREATMENT FOR ADULT T-CELL LEUKEMIA-LYMPHOMA IN AN AFRICAN IMMIGRANT [J].
PAGLIUCA, A ;
LAYTON, DM ;
ALLEN, S ;
MUFTI, GJ .
BRITISH MEDICAL JOURNAL, 1988, 297 (6661) :1456-1457